AIFA Issues Formal Clarification and Refutation Regarding the Share Acquisition Transaction Involving HyalRoute Communication Group Limited

News Market Reaction – AIFA

+2.63%

11 alerts

+2.63% News Effect

+32.5% Peak in 6 hr 20 min

+$391K Valuation Impact

$15.25M Market Cap

0.7x Rel. Volume

On the day this news was published, AIFA gained 2.63%, reflecting a moderate positive market reaction. Argus tracked a peak move of +32.5% during that session. Our momentum scanner triggered 11 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $391K to the company's valuation, bringing the market cap to $15.25M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Share price in deal: US$10.00 per share Implied valuation: US$4.0 billion Target shareholder support: more than 70% +5 more

8 metrics

Share price in deal US$10.00 per share Equity acquisition terms for HyalRoute

Implied valuation US$4.0 billion Implied overall valuation of HyalRoute

Target shareholder support more than 70% Potential HyalRoute equity interests supporting AIFA transaction

Negotiation period approximately three years Duration of negotiations leading to current equity terms

Price change -13.77% AIFA move on the day of clarification release

52-week low 0.3407 AIFA 52-week low price versus current 0.3431

52-week high 0.67 AIFA 52-week high level prior to this news

Market cap 14,843,679 AIFA market capitalization before this news

Market Reality Check

Price: $0.3431 Vol: Volume 573,948 is slightl...

normal vol

$0.3431 Last Close

Volume Volume 573,948 is slightly below the 619,285 20-day average (relative volume 0.93). normal

Technical Price at 0.3431 is trading below the 200-day MA at 0.48 and near the 52-week low of 0.3407.

Peers on Argus

No peers from the stated sector appeared in the momentum scanner, and there are ...

No peers from the stated sector appeared in the momentum scanner, and there are no same-day peer headlines, indicating the -13.77% move in AIFA appears stock-specific rather than sector-driven.

Market Pulse Summary

This announcement clarifies that AIFA’s HyalRoute transaction rests on executed equity and rights ag...

Analysis

This announcement clarifies that AIFA’s HyalRoute transaction rests on executed equity and rights agreements with registered shareholders, at a price of US$10.00 per share and an implied valuation of US$4.0 billion. The company stresses that alleged “fabricated” claims relate to internal shareholder disputes and not its own negotiations, and notes potential support from shareholders representing over 70% of equity interests. Investors may focus on progress toward regulatory approvals, closing conditions, and any updates on tender offer arrangements and further equity consolidation.

Key Terms

tender offer, regulatory approvals, listing rules, equity interests, +1 more

5 terms

tender offer financial

"The Company is currently working with relevant investment banks on possible subsequent tender offer arrangements"

A tender offer is a proposal made by a person or company to buy shares from existing shareholders at a set price, usually higher than the current market value, within a specific time frame. It matters to investors because it can lead to a change in ownership or control of a company, and shareholders must decide whether to sell their shares at the offered price.

regulatory approvals regulatory

"relevant closing conditions, regulatory approvals, and procedural arrangements"

Regulatory approvals are official permissions from government agencies that a company needs before launching a new product, service, or business activity. They matter because without this approval, the company might not be allowed to operate legally or sell its products, similar to how a driver needs a license to legally drive a car.

listing rules regulatory

"The Company will continue to comply with applicable laws, regulations, and listing rules"

Listing rules are the set of requirements a stock exchange and regulators impose on companies to join and stay on the exchange, covering things like financial reporting, disclosures, governance and minimum size. They matter to investors because those rules create a basic level of transparency and behavior—think of them as marketplace rules that make it easier to compare sellers, reduce surprises, and protect liquidity and value; breaking the rules can lead to fines, trading suspensions or delisting.

equity interests financial

"equity interests or related legal rights should be determined by applicable law"

Equity interests are an ownership stake in a company—usually represented by shares or membership units—that give the holder a claim on the business’s profits, assets and sometimes voting power. Think of it as owning one or more slices of a company’s pie: the bigger your slice, the larger your share of dividends, capital gains and influence, and the more you are affected by dilution or company losses. Investors use equity interests to measure value, control and potential returns.

creditors financial

"other shareholders of HyalRoute, as well as other relevant creditors and debt counterparties"

Creditors are people or institutions that have lent money or extended credit to a company and therefore have a legal claim on its future payments or assets. They matter to investors because creditors get paid before shareholders if a company runs into trouble, can influence borrowing costs and financial stability, and their demands or protections can limit what a company can do with its cash—think of them as lenders whose rules shape the business.

AI-generated analysis. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, June 08, 2026 (GLOBE NEWSWIRE) -- All In FutureTech Alliance Inc. (Nasdaq: AIFA) (the “Company” or “AIFA”) recently became aware that the current management team of HyalRoute Communication Group Limited (“HyalRoute”), acting through the personal name of Ms. Dong and through certain Cambodian media outlets and social media channels, has published or disseminated statements alleging that the Company’s May 22, 2026 announcement regarding its acquisition of a controlling equity interest in HyalRoute was “false” or “fabricated.”

The Company hereby issues the following formal statement in response:

I. The Allegation That the Company’s Prior Announcement Was “False” Is Materially Inconsistent With the Facts and Disregards the Lawful Rights of HyalRoute’s Shareholders

The transaction previously disclosed by the Company regarding the acquisition of a controlling interest in HyalRoute is based on a package of equity and rights transaction agreements formally negotiated and signed between the Company and the relevant transaction counterparties. The counterparties involved in the Company’s transaction are the actual shareholders and/or relevant rights holders recorded on HyalRoute’s register of members, including, without limitation, Rainman Network Ltd., Dece Capital Limited, Fair Cheerful Limited, and Yellow River Fiber Optic Ltd.

The Company believes that the public denial of shareholder-level transaction arrangements by certain members of management or the current management team, whether in a management or personal capacity, disregards the lawful rights of HyalRoute’s existing shareholders and is materially inconsistent with the facts presently known to the Company.

The Company respectfully emphasizes that any lawful disposition by shareholders of their equity interests or related legal rights should be determined by applicable law, the company’s constitutional documents, the shareholder register, and formally executed transaction documents, and should not be negated by unilateral statements made by individual members of management.

II. The Transaction Announced by the Company Currently Relates Only to the Shareholder Level and Does Not Yet Extend to the HyalRoute Board or Management Level

The Company specifically clarifies that the transaction previously announced by AIFA currently relates only to equity acquisition arrangements and related rights at the shareholder level of HyalRoute, and does not involve any restructuring, removal, appointment, or takeover arrangements relating to HyalRoute’s current board of directors or management team.

Accordingly, certain recent public statements made by individual members of management with respect to this transaction have conflated shareholder-level equity transaction arrangements with board- or management-level corporate governance arrangements, which may mislead the market and the public.

The Company is currently working with relevant investment banks on possible subsequent tender offer arrangements and further equity consolidation. Based on the information currently available to the Company, such acquisition efforts have also received support and strong interest to participate from certain state-owned shareholders of HyalRoute. The Company expects that, if the relevant transactions and subsequent arrangements proceed smoothly, AIFA’s equity transaction relating to HyalRoute may ultimately receive support from shareholders representing more than 70% of HyalRoute’s equity interests.

III. With Respect to Statements Characterizing the Transaction as “Fabricated” or “False,” the Company Understands That Such Statements Primarily Concern Disputes Among Certain HyalRoute Shareholders and Are Not Related to the Company

In response to statements circulated through certain channels alleging that this transaction is “fabricated” or “false,” the Company understands that such statements primarily concern disputes among certain HyalRoute shareholders and are unrelated to the Company.

The Company’s negotiations and transaction arrangements in connection with this matter are premised solely on dealings with relevant shareholders and/or rights holders in their capacity as registered shareholders of HyalRoute. The Company negotiated and executed transaction documents on the basis of the counterparties’ status as registered shareholders of HyalRoute.

Accordingly, the Company believes that treating internal disputes or disagreements among certain shareholders as grounds to negate transaction arrangements already undertaken by the Company with registered shareholders lacks a factual basis and may mislead the market and the public. The Company will not disregard the objective facts created by duly executed transaction documents and the actual identity of shareholders based on unilateral statements made by individual members of management or other persons through media, social media, or third-party channels.

IV. The Company Will Continue to Advance Relevant Approvals, Closing Procedures, and Subsequent Integration Efforts in a Lawful and Compliant Manner

The Company reminds investors that the HyalRoute transaction is currently still in the process of advancing through the relevant closing conditions, regulatory approvals, and procedural arrangements contemplated by the transaction agreements. The transaction can become effective and close only after the agreed conditions and applicable regulatory approvals have been satisfied.

The Company will continue to comply with applicable laws, regulations, and listing rules, and will timely fulfill its disclosure obligations with respect to approval progress, closing progress, and other material developments relating to the transaction.

The Company also welcomes other shareholders of HyalRoute, as well as other relevant creditors and debt counterparties, to participate in and support this package equity acquisition arrangement on the same acquisition terms as those set forth in the existing executed transactions. After approximately three years of negotiations, the Company has advanced the relevant equity transactions on the basis of the current transaction terms, including a price of US$10.00 per share and an implied overall valuation of US$4.0 billion for HyalRoute. The Company welcomes all relevant parties and management to maintain rational and constructive communication with the Company, so as to jointly promote the steady advancement of the relevant matters on a lawful, compliant basis and with full respect for shareholder rights.

V. The Company Reserves the Right to Pursue Legal Remedies With Respect to False Statements

With respect to any false statements disseminated through media, social media, or other public channels that are materially inconsistent with the facts and may mislead the market, damage the Company’s reputation, or harm investor interests, the Company reserves the right to take all necessary legal measures, including, without limitation, requiring cessation of infringing conduct, demanding clarification of the facts, and pursuing liability in accordance with law.

The Company further reminds all parties that information disclosures by a listed company should be based on the Company’s formal announcements, lawfully disclosed filings, and regulatory filings. Investors are advised to carefully assess the source of information, exercise rational judgment, and be mindful of investment risks.

About All In FutureTech Alliance

All In FutureTech Alliance Inc. (Nasdaq: AIFA), formerly known as Allied Gaming & Entertainment Inc, is a growth-oriented company undergoing a strategic transformation from a global experiential entertainment business into an AI-focused digital infrastructure platform. The Company is pursuing opportunities in artificial intelligence infrastructure, silicon photonics-enabled compute, cross-border fiber-optical network transmission, digital infrastructure services, and technology-enabled growth initiatives. Through its proposed AIFA strategic platform, AIFA aims to build an integrated ecosystem combining AI compute capacity, fiber-optic network infrastructure, AI education and AI applications to support long-term value creation.

Forward-Looking Statements

This press release includes forward-looking statements within the safe harbor provisions provided under federal securities laws, including under the Private Securities Litigation Reform Act of 1995. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results and, consequently, you should not rely on these forward-looking statements as predictions of future events. Important factors that may affect actual results include, among others, the Company’s ability to execute its growth strategy; the outcome of the Nasdaq hearings; market conditions; regulatory changes; operational challenges; and other risks and uncertainties described under “Risk Factors” in the Company’s Annual Report on Form 10-K filed with the SEC on May 22, 2026, and in subsequent filings with the SEC. The foregoing sets forth many, but not all, of the factors that could cause actual results to differ from the Company’s expectations in any forward-looking statement. Readers are cautioned not to place undue reliance upon any forward-looking statements, including but not limited to the Company’s expectation with respect to the effect of the Reverse Stock Split. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law.

Contact:

Investor Relations: ir@alliedgaming.gg